Japanese giant Suntory to partner Aust plant biotech

By Melissa Trudinger
Wednesday, 23 February, 2005

Unlisted Australian horticulture group Oasis Horticulture has teamed up with Japanese beverage company Suntory in an R&D joint venture to develop new plant varieties for the international market.

It's not the first time Suntory has partnered with an Australian plant breeding group -- in 2003 the company bought blue rose breeders Florigene from Nufarm after more than a decade of collaboration.

The new JV, to be known as Bonza Botanicals, will focus on the development of hardier, prettier and unique flowers, according to Oasis finance director Richard Faithorn. The use of genetic modification technology is not planned -- the companies will utilise more standard techniques including cross-breeding and gamma irradiation to introduce new traits.

"Through this major investment, we are convinced that the team can set the benchmark globally for plant and flower development," said Suntory's Shigeru Sarada in a statement. "We are pleased to be working with the Oasis team through Bonza Botanicals, to further develop the group's knowledge and capabilities in providing innovative and market defining intellectual property for next generation plant biotechnology."

Faithorn said the JV was intended to be a long term initiative, and the two companies would share in it equally. "We are looking at it very much as a marriage," he said. While the terms of the JV were not disclosed, Faithorn said it was backed by "pretty significant" funding.

While Australia's market for so-called greenlife is significant -- worth AUD$1.8 billion in the year ending June 30, 2003 -- the marketing focus for the JV will be the giant US and European markets.

Related News

SEQ koala population carries immunity to retrovirus

Koalas from a population north of the Brisbane River appear to have evolved a unique genomic...

RSV immunisation program for babies slashes hospital stays

An Australian-first study has demonstrated the effectiveness of immunisation against respiratory...

A targeted treatment option for psoriasis

New research from MedUni Vienna paves the way for the development of a therapy that not only...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd